Daiichi Sankyo Profile

USD 0.005  0.0138%

Daiichi Sankyo Summary

Daiichi Sankyo Company Limited (DSNKY) is traded on OTC Market in USA. It is located in 3-5-1, Nihonbashi-honcho and employs 14,670 people. The company currently falls under 'Large-Cap' category with current market capitalization of 23 B. Daiichi Sankyo Company Limited has 663.36 M outstanding shares. DAIICHI SANKYO has accumulated about 2.72 B in cash with 939.26 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.14.
Check Daiichi Sankyo Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Daiichi Sankyo Limited Risk Profiles

Key Fundamentals

Daiichi Sankyo Against Markets

Current Ratings

Daiichi Sankyo 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 12% 
Equity ratings for Daiichi Sankyo Company Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Daiichi Sankyo Company, Limited researches, develops, manufactures, imports, and markets pharmaceutical products worldwide. The company was founded in 1899 and is headquartered in Tokyo, Japan. Daiichi Sankyo is traded on OTC Market in USA. more
NameDaiichi Sankyo Company Limited
CEOJoji NakayamaView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address3-5-1, Nihonbashi-honcho
ExchangeOTC Market
Contact Number81 3 6225 1111
CurrencyUSD - US Dollar

Diversify with Daiichi Sankyo Company Limited

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Daiichi Sankyo Company Limited to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Daiichi Sankyo Corporate Directors
Glenn Gormley Senior Managing Executive Officer, Chief Director of Research & Development
Masahiko Ohtsuki Executive Officer, Senior Director of Research in Main Research & Development Unit
Takeshi Ogita Senior Managing Executive Officer, Chief Director of General Affairs and Human Resources, Chief Director of Vaccine Business in Japan Company, Director